Planned Implementation Work Items - 2026
The Trial Use Specification is ready for review by the Stakeholder group and will then be considered ready for implementation. With that in mind, the stakeholder group will continue to refine business rules and to address the following known implementation issues. This work will enhance consistency and provide clarity for implementation of the standard, but these work items are not expected impact the message structures in any significant manner though minor changes may occur.
Implementation work items that are expected to be addressed in 2026, are as follows:
| Work Item | Notes | |
|---|---|---|
| High Cost Drugs - COB Scenarios | If downstream is FHIR and primary is CPHA3 or vice versa | |
| Professional Services - Develop National service code set | ||
| Professional Services - Continue to review scenarios and document use cases | Test the message structure | |
| Technical Overview, API Overview, Operations, etc | Review with Stakeholders and finalize | |
| Capability Statements | Overview, discussion, examples of use | |
| Conformance | Is there a desire for implementers to develop a centralized service | |
| Error message profile to streamline | Included in spec, future use | |
| Detected Issues - to return DUR | Included in spec for future use | |
| Terminology | Some code sets and systems need to be finalized. The Maintenance Process should be documented. | |
| Extensions (New fields) | Stakeholder may bring forth extensions for inclusion in the PCS FHIR specification. |